» Articles » PMID: 25640330

Adjudin Protects Rodent Cochlear Hair Cells Against Gentamicin Ototoxicity Via the SIRT3-ROS Pathway

Overview
Journal Sci Rep
Specialty Science
Date 2015 Feb 3
PMID 25640330
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Hearing loss resulting from hair cell degeneration is a common disease that affects millions of people worldwide. Strategies to overcome the apparent irreversible hair cell loss in mammals become paramount for hearing protection. Here we reported that, by using a well-established gentamicin-induced hair cell loss model in vitro, adjudin, a multi-functional small molecule drug, protected cochlear hair cells from gentamicin damage. Immunohistochemistry, Western blotting and quantitative RT-PCR analyses revealed that adjudin exerted its otoprotective effects by up-regulating the level of Sirt3, a member of Sirtuin family protein located in mitochondria, which regulates reactive oxygen species (ROS) production in cochlear cells and inhibits the production of ROS and apoptotic cells induced by gentamicin. Sirt3 silencing experiments confirmed that Sirt3-ROS signaling axis mediated hair cell protection against gentamicin by adjudin, at least in part. Furthermore, adjudin's otoprotection effects were also observed in an in vivo gentamicin-injured animal model. Taken together, these findings identify adjudin as a novel otoprotective small molecule via elevating Sirt3 levels and Sirt3 may be of therapeutic value in hair cell protection from ototoxic insults.

Citing Articles

Hearing loss during chemotherapy: prevalence, mechanisms, and protection.

Kessler L, Koo C, Richter C, Tan X Am J Cancer Res. 2024; 14(9):4597-4632.

PMID: 39417180 PMC: 11477841. DOI: 10.62347/OKGQ4382.


Ototoxic Effect of Nicotinamide Riboside.

Ivanov S, Podyacheva E, Zhuravskii S, Toropova Y Bull Exp Biol Med. 2024; 177(5):639-642.

PMID: 39340621 DOI: 10.1007/s10517-024-06240-7.


Roles of Sirtuins in Hearing Protection.

Koo C, Richter C, Tan X Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204103 PMC: 11357115. DOI: 10.3390/ph17080998.


Sirtuin insights: bridging the gap between cellular processes and therapeutic applications.

Kamal S, Babar S, Ali W, Rehman K, Hussain A, Akash M Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(12):9315-9344.

PMID: 38976046 DOI: 10.1007/s00210-024-03263-9.


Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders.

DAgnano V, Mariniello D, Pagliaro R, Far M, Schiattarella A, Scialo F Drugs. 2024; 84(5):491-501.

PMID: 38630364 PMC: 11189987. DOI: 10.1007/s40265-024-02021-8.


References
1.
Sano H, Yoneda S, Iwase H, Itoh A, Hashimoto D, Okamoto M . Effect of geranylgeranylacetone on gentamycin ototoxicity in rat cochlea culture. Auris Nasus Larynx. 2006; 34(1):1-4. DOI: 10.1016/j.anl.2006.05.020. View

2.
Okano T, Kelley M . Stem cell therapy for the inner ear: recent advances and future directions. Trends Amplif. 2012; 16(1):4-18. PMC: 4040847. DOI: 10.1177/1084713812440336. View

3.
Kim H, Patel K, Muldoon-Jacobs K, Bisht K, Aykin-Burns N, Pennington J . SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell. 2010; 17(1):41-52. PMC: 3711519. DOI: 10.1016/j.ccr.2009.11.023. View

4.
Fan J, Cai H, Tan W . Role of the plasma membrane ROS-generating NADPH oxidase in CD34+ progenitor cells preservation by hypoxia. J Biotechnol. 2007; 130(4):455-62. DOI: 10.1016/j.jbiotec.2007.05.023. View

5.
Tabuchi K, Pak K, Chavez E, Ryan A . Role of inhibitor of apoptosis protein in gentamicin-induced cochlear hair cell damage. Neuroscience. 2007; 149(1):213-22. DOI: 10.1016/j.neuroscience.2007.06.061. View